Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

EU Approval for Amgen's Prolia
Yahoo/Zacks
Saturday, May 29, 2010 - 9:28am
tags:
Amgen, Prolia, prostate cancer, osteoporosis
Enzon Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Saturday, May 29, 2010 - 9:27am
tags:
Enzon
CytRx Initiates Phase 2 Clinical Trial with Bafetinib in B-cell Chronic Lymphocytic Leukemia
Yahoo/Business Wire
Saturday, May 29, 2010 - 9:26am
tags:
CytRx, leukemia, Bafetinib
What ASCO Can Tell You About Biotechs
Investopedia
Saturday, May 29, 2010 - 9:24am
tags:
biotech, Celgene, Delcath, Roche, Ziopharm, ZymoGenetics, XenoPort
What Investors Think About Dendreon Corp
Motley Fool
Saturday, May 29, 2010 - 9:22am
tags:
Dendreon
Drug stocks end dismal May with another loss
MarketWatch
Saturday, May 29, 2010 - 9:21am
tags:
Cubist Pharmaceuticals, Vivus, Arca pharmaceutical index
Qiagen in Settlement Mode
Yahoo/Zacks
Saturday, May 29, 2010 - 9:19am
tags:
Qiagen, Roche, DxS TheraScreen
Life Tech buys stake in synthetic gene maker
Yahoo/AP
Saturday, May 29, 2010 - 9:16am
tags:
Life Technologies, GEneart
J&J Gets Grilled: FDA Weighs Criminal Penalties Over Manufacturing
WSJ Online
Friday, May 28, 2010 - 11:00am
tags:
JNJ, criminal charges, FDA, recalls
Judge won't toss suit over Wellbutrin generics
Fierce Pharma
Friday, May 28, 2010 - 10:49am
tags:
Wellbutrin, Teva Pharmaceuticals, generics, GSK, lawsuits, Impax
GSK tries an open-source strategy for drug development
Fierce Biotech
Friday, May 28, 2010 - 10:33am
tags:
GSK, drug development, F&D
VaxGen to acquire diaDexus
Bizjournals.com
Friday, May 28, 2010 - 10:06am
tags:
VaxGen, M&A, diaDexus
Teva to stop manufacturing propofol sedative
Reuters
Friday, May 28, 2010 - 9:59am
tags:
Teva Pharmaceuticals, propofol, sedatives
Biotech Stock Mailbag: Neostem
TheStreet.com
Friday, May 28, 2010 - 9:58am
tags:
NeoStem, Cytori, Osiris, Gilead Sciences, stem cells
Dark Horse: Cadila Healthcare
Forbes
Friday, May 28, 2010 - 9:37am
tags:
Cadila, India, H1N1
Glaxo Beat Baxter in U.K. Test of Swine Flu Shots in Children
Bloomberg
Friday, May 28, 2010 - 9:36am
tags:
swine flu, vaccines, GSK, UK, Baxter International
Karo Bio's Prescription: Cheaper Drug Approval
Bloomberg Businessweek
Friday, May 28, 2010 - 8:55am
tags:
Karo Bio, eprotirome
The Death Of The Blockbuster Drug
Forbes
Friday, May 28, 2010 - 8:51am
tags:
generics, Merck, Januvia
AstraZeneca won't file cancer drug submission
Marketwatch
Friday, May 28, 2010 - 8:41am
tags:
Recentin, colorectal cancer, AstraZeneca
Bioethics Expert To FDA: Scrap Glaxo’s Avandia Trial
Pharmalot
Thursday, May 27, 2010 - 8:17pm
tags:
GSK, lawsuits, Avandia, FDA, diabetes, ethics, TIDE

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.